(Q38191014)

30 August 2017

1 reference

title

Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents (English)

1 reference

30 August 2017

author

Maria Laura Belladonna

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24568278%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Ursula Grohmann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24568278%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

2 August 2013

1 reference

Biotechnology and Genetic Engineering Reviews

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24568278%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24568278%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

149-174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24568278%20AND%20SRC:MED&resulttype=core&format=json

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

The toxicology of interleukin-12: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-35-mediated induction of a potent regulatory T cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

The composition and signaling of the IL-35 receptor are unconventional

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interleukin-35: odd one out or part of the family?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interleukin-12: biological properties and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interpreting mixed signals: the cell's cytokine conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Enhancement of soluble protein expression through the use of fusion tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Perspectives of immobilized-metal affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Plasticity and cross-talk of interleukin 6-type cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Potent antitumor activity of interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Fc-based cytokines : prospects for engineering superior therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Conformational stability of pGEX-expressed Schistosoma japonicum glutathione S-transferase: a detoxification enzyme and fusion-protein affinity tag.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Neonatal Fc receptor and IgG-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-12 and IL-23: master regulators of innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Protein therapeutics: a summary and pharmacological classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Denileukin diftitox: a novel immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Antitumor activities of interleukin-27 on melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

A synthetic IgG-binding domain based on staphylococcal protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

A role for IL-27 in early regulation of Th1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Biopharmaceutical drug targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Expression and purification of recombinant proteins by fusion to maltose-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Antiangiogenic and antitumor activities of IL-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

A role for IL-27p28 as an antagonist of gp130-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Gene fusion vectors based on the gene for staphylococcal protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

IL-12 family cytokines: immunological playmakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Making the most of affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Immunotherapy of cancer by IL-12-based cytokine combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

New directions in the basic and translational biology of interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Regulation of immune responses by interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Antiproliferative activity of IL-27 on melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Induction of IgG2a class switching in B cells by IL-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02648725.2013.801228